LifeMD, Inc. (LFMDP)
USD 24.7
(4.11%)
USD 24.7
(4.11%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 148.13 Million USD | 0.32% |
| 2022 | 140.05 Million USD | 8.41% |
| 2021 | 129.18 Million USD | 49.85% |
| 2020 | 86.2 Million USD | 613.18% |
| 2019 | 12.08 Million USD | 43.71% |
| 2018 | 8.41 Million USD | 81.33% |
| 2017 | 4.63 Million USD | 3.84% |
| 2016 | 4.46 Million USD | 262.22% |
| 2015 | 1.23 Million USD | 15.03% |
| 2014 | 1.07 Million USD | -8.63% |
| 2013 | 1.17 Million USD | 7.84% |
| 2012 | 1.08 Million USD | 0.86% |
| 2011 | 1.07 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 43.86 Million USD | 10.73% |
| 2024 Q2 | 49.2 Million USD | 12.18% |
| 2023 Q1 | 31.76 Million USD | 2.77% |
| 2023 Q3 | 38.4 Million USD | 5.81% |
| 2023 Q4 | 39.61 Million USD | 3.17% |
| 2023 FY | 140.5 Million USD | 0.32% |
| 2023 Q2 | 36.29 Million USD | 14.26% |
| 2022 FY | 140.05 Million USD | 8.41% |
| 2022 Q1 | 36.9 Million USD | 3.91% |
| 2022 Q2 | 38.72 Million USD | 4.95% |
| 2022 Q3 | 33.51 Million USD | -13.46% |
| 2022 Q4 | 30.9 Million USD | -7.77% |
| 2021 Q4 | 35.51 Million USD | 9.47% |
| 2021 Q1 | 26.85 Million USD | -34.88% |
| 2021 Q2 | 34.24 Million USD | 27.51% |
| 2021 Q3 | 32.44 Million USD | -5.25% |
| 2021 FY | 129.18 Million USD | 49.85% |
| 2020 Q4 | 41.23 Million USD | 43.17% |
| 2020 Q1 | 4.28 Million USD | 33.66% |
| 2020 Q2 | 10.11 Million USD | 136.09% |
| 2020 Q3 | 28.8 Million USD | 184.68% |
| 2020 FY | 86.2 Million USD | 613.18% |
| 2019 Q3 | 3.42 Million USD | 18.91% |
| 2019 Q4 | 3.2 Million USD | -6.25% |
| 2019 FY | 12.08 Million USD | 43.71% |
| 2019 Q2 | 2.87 Million USD | 11.3% |
| 2019 Q1 | 2.58 Million USD | 13.05% |
| 2018 Q1 | 1.53 Million USD | 22.52% |
| 2018 FY | 8.41 Million USD | 81.33% |
| 2018 Q4 | 2.28 Million USD | -8.35% |
| 2018 Q3 | 2.49 Million USD | 18.76% |
| 2018 Q2 | 2.1 Million USD | 37.25% |
| 2017 Q1 | 596.09 Thousand USD | -78.16% |
| 2017 Q2 | 1 Million USD | 68.37% |
| 2017 Q4 | 1.24 Million USD | -30.21% |
| 2017 FY | 4.63 Million USD | 3.84% |
| 2017 Q3 | 1.78 Million USD | 78.32% |
| 2016 Q1 | 408.18 Thousand USD | -35.63% |
| 2016 FY | 4.46 Million USD | 262.22% |
| 2016 Q3 | 649.39 Thousand USD | -4.49% |
| 2016 Q2 | 679.9 Thousand USD | 66.57% |
| 2016 Q4 | 2.72 Million USD | 320.35% |
| 2015 FY | 1.23 Million USD | 15.03% |
| 2015 Q4 | 634.1 Thousand USD | 237.37% |
| 2015 Q3 | 187.95 Thousand USD | -8.32% |
| 2015 Q2 | 205.02 Thousand USD | -0.59% |
| 2015 Q1 | 206.22 Thousand USD | -35.87% |
| 2014 Q1 | 320.97 Thousand USD | -17.74% |
| 2014 Q4 | 321.56 Thousand USD | 41.78% |
| 2014 Q3 | 226.8 Thousand USD | 11.82% |
| 2014 Q2 | 202.83 Thousand USD | -36.81% |
| 2014 FY | 1.07 Million USD | -8.63% |
| 2013 Q3 | 245.86 Thousand USD | -11.36% |
| 2013 Q2 | 277.38 Thousand USD | 3.23% |
| 2013 Q1 | 268.71 Thousand USD | -12.06% |
| 2013 Q4 | 390.2 Thousand USD | 58.7% |
| 2013 FY | 1.17 Million USD | 7.84% |
| 2012 FY | 1.08 Million USD | 0.86% |
| 2012 Q1 | 184.78 Thousand USD | 0.0% |
| 2012 Q2 | 339.46 Thousand USD | 83.7% |
| 2012 Q3 | 261.9 Thousand USD | -22.85% |
| 2012 Q4 | 305.56 Thousand USD | 16.67% |
| 2011 FY | 1.07 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| CannBioRx Life Sciences Corp. | 13.47 Million USD | -999.134% |
| BIMI International Medical Inc. | 17.28 Million USD | -756.851% |
| China Jo-Jo Drugstores, Inc. | 34.64 Million USD | -327.605% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 89.97 Million USD | -64.645% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 90.12 Million USD | -64.373% |
| Leafly Holdings, Inc. | 44.5 Million USD | -232.875% |
| Leafly Holdings, Inc. | 44.5 Million USD | -232.875% |
| LifeMD, Inc. | 148.13 Million USD | 0.0% |
| TRxADE HEALTH, Inc. | 9.86 Million USD | -1402.138% |
| PetMed Express, Inc. | 86.81 Million USD | -70.644% |
| Walgreens Boots Alliance, Inc. | 40.6 Billion USD | 99.635% |